Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Actelion

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Actelion's 2013 sales performance.

J&J aims for US approval of MS drug ponesimod

J&J aims for US approval of MS drug ponesimod

J&J acquired the S1P receptor modulator as part its $30bn takeover of Actelion, with the FDA application based on the head-to-head phase 3 OPTIMUM study comparing ponesimod to

The mission matters

The mission matters In the words of Jane Griffiths, Global Head of Actelion, this social contract makes our industry uniquely ‘emotionally salient’ and this salience makes the contract fragile.

Darwinian leadership in the life sciences industry

Darwinian leadership in the life sciences industry But it is also because, as Actelion’s Jane Griffith’s said, we touch almost everybody at some point in their lives.

J&J’s ponesimiod tops Aubagio in head-to-head MS trial

J&J’s ponesimiod tops Aubagio in head-to-head MS trial Ponesimod, a S1P receptor modulator acquired as part of J&J’s $30bn acquisition of Actelion in 2017, achieved a statistically significant 30.5% reduction in the annualised relapse rate (ARR)

Hudson named Brandicourt’s successor as Sanofi’s CEO

Hudson named Brandicourt’s successor as Sanofi’s CEO rivals when trying to bolt on Medivation (which went to Pfizer) and Actelion (bought by Johnson &Johnson).

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
OUTiCO

Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics